Cargando…

Yinzhihuang oral liquid protects against non-alcoholic steatohepatitis via modulation of the gut-liver axis in mice

BACKGROUND: Yinzhihuang (YZH) oral liquid is a traditional Chinese medicine compound that has emerged as a promising therapeutic agent for non-alcoholic fatty liver disease (NAFLD). Here, we aimed to investigate the therapeutic effects of YZH on non-alcoholic steatohepatitis (NASH) and elucidate its...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Shuyu, Chen, Fangyuan, Zou, Yanting, Ning, Liuxin, Zhang, Guangcong, Zhang, Shuncai, Yao, Qunyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263770/ https://www.ncbi.nlm.nih.gov/pubmed/35813333 http://dx.doi.org/10.21037/atm-21-4809

Ejemplares similares

Yinzhihuang oral liquid in the treatment of neonatal jaundice: a meta-analysis
por: Zeng, Jie, et al.
Publicado: (2016)

Anti-PCSK9 Treatment Attenuates Liver Fibrosis via Inhibiting Hypoxia-Induced Autophagy in Hepatocytes
por: Ning, Liuxin, et al.
Publicado: (2023)

Yin Zhi Huang, a traditional Chinese herbal formula, ameliorates diet-induced obesity and hepatic steatosis by activating the AMPK/SREBP-1 and the AMPK/ACC/CPT1A pathways
por: Yao, Qunyan, et al.
Publicado: (2020)

Clinicopathological significance of the microRNA‐146a/WASP‐family verprolin‐homologous protein‐2 axis in gastric cancer
por: Yao, Qunyan, et al.
Publicado: (2017)

Network Pharmacology-Based Analysis on the Potential Biological Mechanisms of Yinzhihuang Oral Liquid in Treating Neonatal Hyperbilirubinemia
por: Liang, Tianqi, et al.
Publicado: (2022)

Effects and therapeutic mechanism of Yinzhihuang on steatohepatitis in rats induced by a high‐fat, high‐cholesterol diet
por: Zeng, Jing, et al.
Publicado: (2020)

Yinzhihuang oral liquid combined with phototherapy for neonatal jaundice: a systematic review and meta-analysis of randomized clinical trials
por: Wu, Ruo-han, et al.
Publicado: (2018)

Smurf2 suppresses the metastasis of hepatocellular carcinoma via ubiquitin degradation of Smad2
por: Song, Dongqiang, et al.
Publicado: (2022)

Exploring the effect of Yinzhihuang granules on alcoholic liver disease based on pharmacodynamics, network pharmacology and molecular docking
por: Tan, Yingying, et al.
Publicado: (2023)

Correction: Exploring the effect of Yinzhihuang granules on alcoholic liver disease based on pharmacodynamics, network pharmacology and molecular docking
por: Tan, Yingying, et al.
Publicado: (2023)

Lentinan Supplementation Protects the Gut–Liver Axis and Prevents Steatohepatitis: The Role of Gut Microbiota Involved
por: Yang, Xiaoying, et al.
Publicado: (2022)

Val‐Val‐Tyr‐Pro protects against non‐alcoholic steatohepatitis in mice by modulating the gut microbiota and gut‐liver axis activation
por: Xie, Xinshu, et al.
Publicado: (2021)

Placental Growth Factor Contributes to Liver Inflammation, Angiogenesis, Fibrosis in Mice by Promoting Hepatic Macrophage Recruitment and Activation
por: Li, Xi, et al.
Publicado: (2017)

Pro‐inflammatory signalling and gut‐liver axis in non‐alcoholic and alcoholic steatohepatitis: Differences and similarities along the path
por: Glaser, Trenton, et al.
Publicado: (2020)

Myricetin Modulates Macrophage Polarization and Mitigates Liver Inflammation and Fibrosis in a Murine Model of Nonalcoholic Steatohepatitis
por: Yao, Qunyan, et al.
Publicado: (2020)

Yinzhihuang injection induces apoptosis and suppresses tumor growth in acute myeloid leukemia cells
por: Huang, Zhe, et al.
Publicado: (2023)

Proprotein Convertase Subtilisin/Kexin Type 9 Promotes Gastric Cancer Metastasis and Suppresses Apoptosis by Facilitating MAPK Signaling Pathway Through HSP70 Up-Regulation
por: Xu, Beili, et al.
Publicado: (2021)

MicroRNA-146a promote cell migration and invasion in human colorectal cancer via carboxypeptidase M/src-FAK pathway
por: Lu, Di, et al.
Publicado: (2017)

Effects of Yinzhihuang Granules on Serum Liver Enzymes in Jaundice Patients: A Real-World Study Based on HIS Data
por: Zhang, Cheng, et al.
Publicado: (2020)

Flaxseed Powder Attenuates Non-Alcoholic Steatohepatitis via Modulation of Gut Microbiota and Bile Acid Metabolism through Gut–Liver Axis
por: Yang, Chao, et al.
Publicado: (2021)

A bioinformatics investigation into molecular mechanism of Yinzhihuang granules for treating hepatitis B by network pharmacology and molecular docking verification
por: Zhang, Jingyuan, et al.
Publicado: (2020)

Accurate liquid biopsy for the diagnosis of non-alcoholic steatohepatitis and liver fibrosis
por: Angelini, Giulia, et al.
Publicado: (2023)

Exploring the Multicomponent Synergy Mechanism of Yinzhihuang Granule in Inhibiting Inflammation-Cancer Transformation of Hepar Based on Integrated Bioinformatics and Network Pharmacology
por: Zhang, Jingyuan, et al.
Publicado: (2022)

Gut microbiota contribution to hepatocellular carcinoma manifestation in non-alcoholic steatohepatitis
por: Liakina, Valentina, et al.
Publicado: (2022)

Effect of acupressure combined with Yinzhihuang granules on neonatal jaundice: a systematic review and meta-analysis of randomized controlled trials
por: Wu, Fang-Fang, et al.
Publicado: (2022)

Oral arginine supplementation protects female mice from the onset of non-alcoholic steatohepatitis
por: Sellmann, Cathrin, et al.
Publicado: (2017)

Spirulina Liquid Extract Protects against Fibrosis Related to Non-Alcoholic Steatohepatitis and Increases Ursodeoxycholic Acid
por: Coué, Marine, et al.
Publicado: (2019)

Saccharomyces Boulardii Ameliorates Non-alcoholic Steatohepatitis in Mice Induced by a Methionine-Choline-Deficient Diet Through Gut-Liver Axis
por: Yang, An-Ming, et al.
Publicado: (2022)

Combined alcoholic and non-alcoholic steatohepatitis
por: Ntandja Wandji, Line Carolle, et al.
Publicado: (2020)

Tyrosine kinase receptor B attenuates liver fibrosis by inhibiting TGF-β/SMAD signaling
por: Song, Yu, et al.
Publicado: (2023)

Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis
por: Baumann, Anja, et al.
Publicado: (2020)

Fructose and Non-Alcoholic Steatohepatitis
por: Roeb, Elke, et al.
Publicado: (2021)

Statins in Non-alcoholic Steatohepatitis
por: Torres-Peña, Jose D., et al.
Publicado: (2021)

Rifaximin Ameliorates Non-alcoholic Steatohepatitis in Mice Through Regulating gut Microbiome-Related Bile Acids
por: Jian, Jie, et al.
Publicado: (2022)

Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis
por: Baker, Susan S., et al.
Publicado: (2010)

The Flavonoid Quercetin Ameliorates Liver Inflammation and Fibrosis by Regulating Hepatic Macrophages Activation and Polarization in Mice
por: Li, Xi, et al.
Publicado: (2018)

Jiang Zhi Granule protects immunological barrier of intestinal mucosa in rats with non-alcoholic steatohepatitis
por: Yu, Xiao, et al.
Publicado: (2021)

New pathway ameliorating ulcerative colitis: focus on Roseburia intestinalis and the gut–brain axis
por: Xu, Fenghua, et al.
Publicado: (2021)

Berberine Alleviates Non-alcoholic Steatohepatitis Through Modulating Gut Microbiota Mediated Intestinal FXR Activation
por: Shu, Xiangbing, et al.
Publicado: (2021)

Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development
por: Mouries, Juliette, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6s1aj6phg3fv780gtb6hg19u46